Activation of Second US Pivotal Trial Site, Mayo Clinic
Filed with ASX · · 4 pages · English
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- Emu Pivotal Validation Trial Commences
- First Responder Scanner in Successful Aeromedical Testing
- S&P DJI Announces March 2025 Quarterly Rebalance
- EMVision Releases its FY25 Half Yearly Report
- US Ethics Approval Received for Pivotal Validation Trial
Later from EMvision Medical Devices
- Enhanced Algorithm Performance From Continuous Innovation
- Additional Pivotal Trial Site Activations
- EMVision Awarded $5m Non-Dilutive Government Grant
- Key Developments in Pivotal Trial & Innovation Study
- First Responder Program Advanced & Grant Milestone Achieved
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices